Adlai Nortye (ANL) Debt Ratio (2022 - 2026)
Adlai Nortye (ANL) posted quarterly Debt Ratio of 0.71 for Q4 2025, up 93.24% year-over-year from 0.37 in Q4 2024, and up 16.75% quarter-over-quarter from 0.61 in Q2 2025.
Analysis
Adlai Nortye (ANL) Debt Ratio (2022 - 2026) Analysis & Trends
Adlai Nortye (ANL) has reported Debt Ratio for 4 consecutive years, with 0.71 the latest figure, recorded in Q4 2025.
- In Q4 2025, Debt Ratio rose 93.24% year-over-year to 0.71; the TTM figure through Dec 2025 stood at 0.71 (up 93.24% YoY), while the FY2025 annual figure was 0.71, up 93.24% from the prior year.
- Debt Ratio rose to 0.71 in Q4 2025 per ANL's latest filing, from 0.61 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.71 in Q4 2025 and bottomed at 0.06 in Q4 2022.
- Historically, Debt Ratio has averaged 0.39 across 4 years, with a median of 0.37 in 2024.
- Annual changes were most pronounced in 2023 — Debt Ratio soared 293.02% — and 2024, when it soared 58.44%.
- Adlai Nortye's Debt Ratio stood at 0.06 in 2022, then jumped by 293.02% to 0.23 in 2023, then jumped by 58.44% to 0.37 in 2024, then soared by 93.24% to 0.71 in 2025.
- Business Quant data shows ANL's Debt Ratio at 0.71 in Q4 2025, 0.61 in Q2 2025, and 0.37 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.05 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.47 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.26 |
| 10 | Adlai Nortye | 500.08 Mn | 268.19 Mn | - | 0.10 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.10 |
| Dec 31, 2025 | 0.71 |
| Jun 30, 2025 | 0.61 |
| Dec 31, 2024 | 0.37 |
| Jun 30, 2024 | 0.36 |
| Dec 31, 2023 | 0.47 |
| Dec 31, 2022 | 0.12 |